Amylyx withdraws ALS Drug Relyvrio after Phase 3 trial failure
USA—Amylyx Pharmaceuticals Inc. has announced the initiation of the process to withdraw its drug,...
Read More
Tag: USFDA
Kenya’s PPB joins International Medical Device Audit Program
KENYA— The Pharmacy and Poisons Board (PPB) has been designated as an MDSAP Affiliate Member of...
Read More
FDA approves Axsome Therapeutics’ Auvelity, the first rapid-acting oral treatment for depression
USA- The US Food and Drug Administration (FDA) has approved Auvelity by Axsome Therapeutics (US)...
Read More
Huge blow to Gilead’s and Merck’s HIV strategy as safety concerns mar once-weekly HIV drug combination
USA – Gilead Sciences, Inc. and Merck have temporarily suspended enrollment in a Phase 2...
Read More
AstraZeneca unveils new discovery center (DISC) in Cambridge, UK
UNITED KINGDOM – AstraZeneca, a global, science-led biopharmaceutical company has opened a...
Read More
Boehringer Ingelheim’s Jardiance scores marketing nod in India for additional indication
INDIA – Indian drug regulator, the Drugs Controller General of India (DCGI) has given Boehringer...
Read More
LATEST DIGITAL MAGAZINE
